Team presents updated results from Phase 3 trial of IVIG for Alzheimer's disease
Weill Cornell Medical College neurologist Dr. Norman Relkin reported new findings today from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer's disease at the Alzheimer's Association ...
Jul 16, 2013
0
1